Nomo Diagnostics Inc. is standardizing and automating validated real-time concussion detection for athletes and soldiers to better manage brain health. The firm seeks to redefine the experience of concussed individuals through early objective identification, thus modernizing the current standard of care involving a paper and pencil questionnaire. NoMo's platform technology has the potential to become the gold standard in concussion identification with a direct physiological measurement of the brainwave immediately upon an impact event. The technology, incubated at Columbia University through a the Columbia-Coulter Translational Research Partnership through a grant from the Coulter Foundation, will provide an immediate assessment on the field of play or during military conflict via a miniaturized quantitative electroencephalogram (qEEG) with novel biosensor which can be sent to the sideline or military command center through telemetry prompting immediate action by health personnel.
